Navigation Links
Vanda Pharmaceuticals to Announce First Quarter 2017 Financial Results on May 2, 2017
Date:4/13/2017

WASHINGTON, April 13, 2017 /PRNewswire/ -- Conference Call and Webcast to Follow

Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced it will release results for the first quarter of 2017 on Tuesday, May 2, 2017, after the market closes.

Vanda will host a conference call at 4:30 PM ET on Tuesday, May 2, 2017, during which management will discuss the first quarter 2017 financial results and other corporate activities. To participate in the conference call, please dial 1-800-708-4539 (domestic) or 1-847-619-6396 (international) and use passcode 44748467.

The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Tuesday, May 2, 2017, beginning at 7:00 PM ET and will be accessible until Tuesday, May 9, 2017, at 11:59 PM ET. The replay call-in number is 1-888-843-7419 for domestic callers and 1-630-652-3042 for international callers.  The passcode number is 44748467.

ABOUT VANDA PHARMACEUTICALS INC.:
Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.

Investor Contact:
Jim Kelly
Executive Vice President & Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-first-quarter-2017-financial-results-on-may-2-2017-300439682.html


'/>"/>
SOURCE Vanda Pharmaceuticals Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland
2. Vanda to Present Tasimelteon Non-24 Phase III Data at Two Medical Meetings
3. Vanda Announces Submission To FDA Of A New Drug Application For Tasimelteon For The Treatment Of Non-24-Hour Disorder In The Totally Blind
4. Vanda Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare Conference
5. Vanda Presents Data From Tasimelteon Phase III Studies In Non-24-Hour Disorder
6. Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
7. Vanda Pharmaceuticals, Inc. Sued by Investor
8. Vanda Pharmaceuticals to Participate in Upcoming Investor Conferences
9. Vanda Pharmaceuticals to Announce Second Quarter 2013 Financial Results on July 31, 2013
10. Vanda Pharmaceuticals Reports Second Quarter 2013 Results
11. UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of August 24, 2013 to Seek a Lead Plaintiff Position
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2017)... , May 4, 2017  Fortuna Fix Inc. (" ... to be the first to eliminate the need for embryonic ... cells to treat neurodegenerative diseases. Fortuna ... with Professor Michael Fehlings , MD, PhD; Father ... , MD, MPH; and Professor James Giordano , PhD. ...
(Date:5/4/2017)...  A new tight-tolerance microextrusion medical tubing product ... is being launched by Natvar, a Tekni-Plex company. ... recent years to service a wide variety of ... expensive materials such as glass and fluoropolymers have ... their ability to consistently hold tolerances. This is ...
(Date:5/3/2017)... , May 3, 2017  West Pharmaceutical Services, ... solutions for injectable drug administration, announced today that ... and Technical Services, and Diane Paskiet , ... offering presentations focused on West,s expertise in the ... as well as providing commentary on updated industry ...
Breaking Medicine Technology:
(Date:5/22/2017)... ... 22, 2017 , ... Faithfully following pop culture, people today are forever in ... shaped through fitness programs. It carries on to skin nourished, pampered and nurtured to ... radiant smile. CDA has found that just like a perfectly cut and ...
(Date:5/22/2017)... ... 2017 , ... OSF Ventures, the corporate investment arm of ... stage company in San Francisco that has developed software to individualize treatment based ... acted as the lead investor in the round. , Medicine is typically ...
(Date:5/21/2017)... ... May 19, 2017 , ... HealthSmart, the ... of James (Jim) Vertino as Chief Information Officer (CIO). He will be joining ... drives innovation and business performance. He defines strategic roadmaps by reimagining business processes—bridging ...
(Date:5/21/2017)... Viejo, CA (PRWEB) , ... May 20, 2017 ... ... self-animating, paragraph styled corporate text designs created specifically for use in Final Cut ... editing process for all media productions. Pixel Film Studios’ ProParagraph Corporate will deliver ...
(Date:5/21/2017)... ... May 21, 2017 , ... ... brought together a cross-disciplinary group of scholars, policymakers, and activists wanting to address ... and Equity is the third book from a recent series of from ...
Breaking Medicine News(10 mins):